85 related articles for article (PubMed ID: 23707514)
1. Fasting reduces liver fibrosis in a mouse model for chronic cholangiopathies.
Sokolović A; van Roomen CP; Ottenhoff R; Scheij S; Hiralall JK; Claessen N; Aten J; Oude Elferink RP; Groen AK; Sokolović M
Biochim Biophys Acta; 2013 Oct; 1832(10):1482-91. PubMed ID: 23707514
[TBL] [Abstract][Full Text] [Related]
2. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
[TBL] [Abstract][Full Text] [Related]
3. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(-/-) mice.
Sokolović A; Rodriguez-Ortigosa CM; Bloemendaal LT; Oude Elferink RP; Prieto J; Bosma PJ
Biochim Biophys Acta; 2013 Jun; 1832(6):697-704. PubMed ID: 23416526
[TBL] [Abstract][Full Text] [Related]
5. [The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis].
Wu XR; Lv MH; Wang Q; Shi SS; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):400-2. PubMed ID: 15268802
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of insulin like growth factor binding protein 5 reduces liver fibrosis in chronic cholangiopathy.
Sokolović A; Montenegro-Miranda PS; de Waart DR; Cappai RM; Duijst S; Sokolović M; Bosma PJ
Biochim Biophys Acta; 2012 Jun; 1822(6):996-1003. PubMed ID: 22434064
[TBL] [Abstract][Full Text] [Related]
7. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
[TBL] [Abstract][Full Text] [Related]
8. C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice.
Chu PS; Nakamoto N; Ebinuma H; Usui S; Saeki K; Matsumoto A; Mikami Y; Sugiyama K; Tomita K; Kanai T; Saito H; Hibi T
Hepatology; 2013 Jul; 58(1):337-50. PubMed ID: 23460364
[TBL] [Abstract][Full Text] [Related]
9. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
Kim WH; Matsumoto K; Bessho K; Nakamura T
Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
[TBL] [Abstract][Full Text] [Related]
12. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
13. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
[TBL] [Abstract][Full Text] [Related]
14. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
[TBL] [Abstract][Full Text] [Related]
15. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
[TBL] [Abstract][Full Text] [Related]
16. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice.
Roderfeld M; Rath T; Voswinckel R; Dierkes C; Dietrich H; Zahner D; Graf J; Roeb E
Hepatology; 2010 Jan; 51(1):267-76. PubMed ID: 19827165
[TBL] [Abstract][Full Text] [Related]
18. Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis.
Cong M; Liu T; Wang P; Fan X; Yang A; Bai Y; Peng Z; Wu P; Tong X; Chen J; Li H; Cong R; Tang S; Wang B; Jia J; You H
Am J Pathol; 2013 May; 182(5):1607-16. PubMed ID: 23474083
[TBL] [Abstract][Full Text] [Related]
19. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
Bergheim I; Guo L; Davis MA; Duveau I; Arteel GE
J Pharmacol Exp Ther; 2006 Feb; 316(2):592-600. PubMed ID: 16221737
[TBL] [Abstract][Full Text] [Related]
20. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
